Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD

Blood (2018) 132 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2018-99-115768

Published: 2018

Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD

Blood (2016) 128 (22): 649.

https://doi.org/10.1182/blood.V128.22.649.649

Published: 2016

Journal Articles

ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant

Zhongwen Liu, MD, Hongxing Liu, MD, Yanli Zhang, MD, Dai Kong, MD, Jie Shi, MD, Yin Zhang, MD, Meiying Wen, Yongping Song, MD PhD, Chunrong Tong, MD, Mingyi Chen, MD PhD, William J. Murphy, PhD, Kai Sun, MD PhD

Blood (2015) 126 (23): 5403.

https://doi.org/10.1182/blood.V126.23.5403.5403

Published: 2015

Journal Articles

Mutaome Profiling and Retrospective Mutaome Profiling Using Archived Bone Marrow Smear In AML

Hongxing Liu, MD, Fang Wang, MD, Wen Teng, Yuehui Lin, MD, Junfang Yang, MD., Xian Zhang, Qing Yin, Xue Chen, Ping Zhu, MD, Chunrong Tong, MD

Blood (2013) 122 (21): 4983.

https://doi.org/10.1182/blood.V122.21.4983.4983

Published: 2013

Journal Articles

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Hongxing Liu, MD, Fang Wang, MD, Juan Zhu, MD, Hui Wang, MD, Ping Wu, MD, Wen Teng, Xu Han, Jianfeng Zhang, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4927.

https://doi.org/10.1182/blood.V118.21.4927.4927

Published: 2011

Journal Articles

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Hongxing Liu, MD, Wenjun Tian, MD, Fang Wang, MD, Juan Zhu, MD, Wen Teng, Hui Wang, MD, Tong Wang, MD, Ping Wu, MD, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4912.

https://doi.org/10.1182/blood.V118.21.4912.4912

Published: 2011

Journal Articles

High Frequency of Familial Hemophagocytic Lymphocytosis Associated Immune Gene Defects In Refractory Viral Infection of Unknown Origin

Chunrong Tong, MD, Hongxing Liu, Jianjun Xie, MD, Hui Wang, MD, Xian Zhang, MD, Fang Wang, Juan Zhu, Wen Teng, Jiangying Gu, MD, Yali Zhang, MD, Wenjun Ling, MD, Tong Wu, MD, Dao-Pei Lu, MD

Blood (2010) 116 (21): 2775.

https://doi.org/10.1182/blood.V116.21.2775.2775

Published: 2010

Journal Articles

Clonal Evolution of BCR-ABL1 Kinase Domain Mutation In Tyrosine Kinase Inhibitor Treatment Patient

Hongxing Liu, Ping Zhu, MD, Chunrong Tong, MD, Yanli Zhao, Peng Cai, Juan Zhu, Fang Wang, Jiangying Gu, MD, Jianjun Xie, MD, Xian Zhang, MD, Dao-Pei Lu, MD

Blood (2010) 116 (21): 597.

https://doi.org/10.1182/blood.V116.21.597.597

Published: 2010

Journal Articles

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Chunrong Tong, MD, Junfang Yang, MD, Yuehui Lin, MD, Xinhong Fei, MD, Jie Zhao, MD, Xian Zhang, MD, Jiangying Gu, MD, Tong Wu, MD, Dao-Pei Lu, MD, Hui Wang, MD

Blood (2010) 116 (21): 1661.

https://doi.org/10.1182/blood.V116.21.1661.1661

Published: 2010

NARROW

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant

Mutaome Profiling and Retrospective Mutaome Profiling Using Archived Bone Marrow Smear In AML

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

High Frequency of Familial Hemophagocytic Lymphocytosis Associated Immune Gene Defects In Refractory Viral Infection of Unknown Origin

Clonal Evolution of BCR-ABL1 Kinase Domain Mutation In Tyrosine Kinase Inhibitor Treatment Patient

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only